Fast Five Quiz: Management of Mantle Cell Lymphoma

Elwyn C. Cabebe, MD; Ann S. LaCasce, MD, MMSc


January 26, 2023

Mantle cell lymphoma (MCL) is a rare subtype of B-cell non-Hodgkin lymphoma. As with many other B-cell malignancies, MCL comprises a wide variety of biological and clinical variants. Consequently, its diagnosis can be challenging. The disease course in most cases is aggressive, highlighting the importance of effective management. In recent decades, improved outcomes of frontline regimens as well as the introduction of several new and emerging agents have ushered in a new era in the management of MCL, with a median overall survival of up to 9.4 years.

How familiar are you with the management of MCL? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.